Trial intelligence / Profile preview

Vasoconstrictors vs Albumin After Large Volume Paracentesis in Cirrhosis

NCT00108355Phase 4Completed

Sponsor
United States Department of Veterans Affairs
Start
Dec 2003
Primary completion
Aug 2010
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Octreotide long-acting injection, midodrine in ascites, Cirrhosis, sponsored by United States Department of Veterans Affairs. Started Dec 2003; status: completed.

02

Drugs

Octreotide long-acting injectionmidodrine
03

Conditions

ascitesCirrhosis

Beyond the preview

Go deeper on NCT00108355.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00108355.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call